Cargando…

Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy

Detalles Bibliográficos
Autores principales:	Casadevall, Arturo, Joyner, Michael J, Pirofski, Liise-anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543274/ https://www.ncbi.nlm.nih.gov/pubmed/32805024 http://dx.doi.org/10.1093/cid/ciaa1213

Ejemplares similares

Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic
por: Pirofski, Liise-anne
Publicado: (2021)

Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023)

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
por: Focosi, Daniele, et al.
Publicado: (2022)

The Assessment of Convalescent Plasma Efficacy against COVID-19
por: Casadevall, Arturo, et al.
Publicado: (2020)

COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
por: Focosi, Daniele, et al.
Publicado: (2021)

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
por: Casadevall, Arturo, et al.
Publicado: (2021)

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study
por: Rogers, Ralph, et al.
Publicado: (2020)

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)

COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
por: Pirofski, Liise-anne
Publicado: (2023)

The Ebola Epidemic Crystallizes the Potential of Passive Antibody Therapy for Infectious Diseases
por: Casadevall, Arturo, et al.
Publicado: (2015)

Exploiting the Redundancy in the Immune System: Vaccines Can Mediate Protection by Eliciting ‘Unnatural’ Immunity
por: Casadevall, Arturo, et al.
Publicado: (2003)

Convalescent plasma to deliver therapeutic antibodies against COVID-19
por: Senefeld, Jonathon W., et al.
Publicado: (2022)

Rethinking T cell immunity in oropharyngeal candidiasis
por: Pirofski, Liise-anne, et al.
Publicado: (2009)

What is infectiveness and how is it involved in infection and immunity?
por: Pirofski, Liise-anne, et al.
Publicado: (2015)

Immune-Mediated Damage Completes the Parabola: Cryptococcus neoformans Pathogenesis Can Reflect the Outcome of a Weak or Strong Immune Response
por: Pirofski, Liise-anne, et al.
Publicado: (2017)

The Use of Convalescent Plasma Therapy on COVID-19 Filipino Patients: A Tertiary Center Experience
por: Velasco, Manuel Reyes, et al.
Publicado: (2022)

Use of convalescent plasma in the treatment of COVID-19
por: Joyner, Michael J., et al.
Publicado: (2023)

Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection
por: Pedraza, Alexandra, et al.
Publicado: (2022)

Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis
por: Zeng, Chengbo, et al.
Publicado: (2022)

A Comparative Analysis of Statistical Methods to Estimate the Reproduction Number in Emerging Epidemics, With Implications for the Current Coronavirus Disease 2019 (COVID-19) Pandemic
por: O’Driscoll, Megan, et al.
Publicado: (2020)

The emergency use authorization for COVID‐19 convalescent plasma reduced mortality
por: Paneth, Nigel, et al.
Publicado: (2023)

Q and A What is a pathogen? A question that begs the point
por: Pirofski, Liise-anne, et al.
Publicado: (2012)

The Damage–Response Framework as a Tool for the Physician-Scientist to Understand the Pathogenesis of Infectious Diseases
por: Pirofski, Liise-anne, et al.
Publicado: (2018)

Benefits and Costs of Animal Virulence for Microbes
por: Casadevall, Arturo, et al.
Publicado: (2019)

Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
por: Pirofski, Liise-anne, et al.
Publicado: (2020)

Immunomodulators as an antimicrobial tool
por: Pirofski, Liise-anne, et al.
Publicado: (2006)

The damage-response framework of microbial pathogenesis
por: Casadevall, Arturo, et al.
Publicado: (2003)

The weapon potential of a microbe
por: Casadevall, Arturo, et al.
Publicado: (2004)

The Damage-Response Framework of Microbial Pathogenesis and Infectious Diseases
por: Pirofski, Liise-anne, et al.
Publicado: (2008)

Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
por: Sullivan, David J, et al.
Publicado: (2022)

Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
por: Haidar, Ghady, et al.
Publicado: (2021)

Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021)

Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
por: Klassen, Stephen A., et al.
Publicado: (2021)

Convalescent plasma for COVID-19. TSUNAMI is not the final word
por: Franchini, Massimo, et al.
Publicado: (2022)

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020)

A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19)
por: Peluso, Michael J, et al.
Publicado: (2020)

Use of convalescent plasma in COVID‐19 patients with immunosuppression
por: Senefeld, Jonathon W., et al.
Publicado: (2021)

Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
por: Wang, Kai, et al.
Publicado: (2020)

Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores
por: Hoenigl, Martin
Publicado: (2020)

Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness
por: Flannery, Brendan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8sq2rls936bjl4hrorfoseir43